Terms: = Head and neck cancer AND MAX, MGC36767, 4149, ENSG00000125952, MGC18164, MGC10775, P61244, MGC11225, orf1, MGC34679 AND Prognosis
87 results:
1. Updates on the genetics of multiple endocrine neoplasia.
Sahakian N; Castinetti F; Romanet P; Reznik Y; Brue T
Ann Endocrinol (Paris); 2024 Apr; 85(2):127-135. PubMed ID: 38325596
[TBL] [Abstract] [Full Text] [Related]
2. Methylation-Mediated Silencing of ATF3 Promotes Thyroid cancer Progression by Regulating Prognostic Genes in the MAPK and PI3K/AKT Pathways.
Xiao X; Chen M; Sang Y; Xue J; Jiang K; Chen Y; Zhang L; Yu S; Lv W; Li Y; Liu R; Xiao H
Thyroid; 2023 Dec; 33(12):1441-1454. PubMed ID: 37742107
[No Abstract] [Full Text] [Related]
3. The extent of unnecessary tooth loss due to extractions prior to radiotherapy based on radiation field and dose in patients with head and neck cancer.
Buurman DJM; Speksnijder CM; Granzier ME; Timmer VCML; Hoebers FJP; Kessler P
Radiother Oncol; 2023 Oct; 187():109847. PubMed ID: 37543058
[TBL] [Abstract] [Full Text] [Related]
4. A systematic review and meta-analysis of predictive and prognostic models for outcome prediction using positron emission tomography radiomics in head and neck squamous cell carcinoma patients.
Philip MM; Welch A; McKiddie F; Nath M
Cancer Med; 2023 Aug; 12(15):16181-16194. PubMed ID: 37353996
[TBL] [Abstract] [Full Text] [Related]
5. Prognostic value of baseline
Xia L; Li X; Zhu J; Gao Z; Zhang J; Yang G; Wang Z
Radiat Oncol; 2023 Feb; 18(1):41. PubMed ID: 36829219
[TBL] [Abstract] [Full Text] [Related]
6. [
Ferrari C; Santo G; Mammucci P; Rubini D; Sciacqua A; Sardaro A; Pisani AR; Rubini G
BMC Med Imaging; 2023 Feb; 23(1):34. PubMed ID: 36814217
[TBL] [Abstract] [Full Text] [Related]
7. Assessing the variability and correlation between SUV and ADC parameters of head and neck cancers derived from simultaneous PET/MRI: A single-center study.
Wongsa P; Nantasuk M; Singhnoi S; Pawano P; Jantarato A; Siripongsatian D; Lerdsirisuk P; Phonlakrai M
J Appl Clin Med Phys; 2023 May; 24(5):e13928. PubMed ID: 36763489
[TBL] [Abstract] [Full Text] [Related]
8.
Abraham AG; Riauka T; Hudson M; Ghosh S; Zebak S; Alba V; Vaihenberg E; Warkentin H; Tankel K; Severin D; Bedard E; Spratlin J; Mulder K; Joseph K
Clin Oncol (R Coll Radiol); 2023 Mar; 35(3):177-187. PubMed ID: 36402622
[TBL] [Abstract] [Full Text] [Related]
9. High expression of HNRNPR in ESCA combined with
Liu XY; Gao Y; Kui XY; Liu XS; Zhang YH; Zhang Y; Ke CB; Pei ZJ
J Transl Med; 2022 Oct; 20(1):450. PubMed ID: 36195940
[TBL] [Abstract] [Full Text] [Related]
10. Quantitative CT evaluation after two cycles of induction chemotherapy to predict prognosis of patients with locally advanced oesophageal squamous cell carcinoma before undergoing definitive chemoradiotherapy/radiotherapy.
Yan S; Shi YJ; Liu C; Li XT; Zhao B; Wei YY; Shen L; Lu ZH; Sun YS
Eur Radiol; 2023 Jan; 33(1):380-390. PubMed ID: 35927466
[TBL] [Abstract] [Full Text] [Related]
11. Early postoperative weight loss is associated with poor prognosis in patients with esophageal cancer.
Yamamoto K; Tanaka K; Yamasaki M; Yamashita K; Makino T; Saito T; Yamamoto K; Takahashi T; Kurokawa Y; Nakajima K; Eguchi H; Doki Y
Esophagus; 2022 Oct; 19(4):596-603. PubMed ID: 35857177
[TBL] [Abstract] [Full Text] [Related]
12. Pretreatment [
Gihbid A; Cherkaoui Salhi G; El Alami I; Belgadir H; Tawfiq N; Bendahou K; El Mzibri M; Cadi R; El Benna N; Guensi A; Khyatti M
Ann Nucl Med; 2022 Oct; 36(10):876-886. PubMed ID: 35836088
[TBL] [Abstract] [Full Text] [Related]
13. Acinic cell carcinoma of the parotid gland: Timeo Danaos et dona ferentes? A multicenter retrospective analysis focusing on survival outcome.
De Luca P; de Campora L; Tassone D; Atturo F; Colangeli R; Petruzzi G; Fermi M; Molinari G; Abeshi A; Cintoli G; Lo Manto A; Togo G; Ricciardiello F; Condorelli P; Raso F; Di Stadio A; Salzano G; Esposito E; D'Ecclesia A; Radici M; Iemma M; Vigili MG; Salzano FA; Magaldi L; Cassano M; Dallan I; Pellini R; Presutti L; Ionna F; de Campora E; Camaioni A
Eur Arch Otorhinolaryngol; 2022 Dec; 279(12):5821-5829. PubMed ID: 35678874
[TBL] [Abstract] [Full Text] [Related]
14. Association of immune response with overall and disease-free survival in laryngeal squamous cell carcinomas.
Bayrak AF; Eliyatkın NÖ; İşlek A; Özkul Y; Kılıç HS; Aktas S
Am J Otolaryngol; 2022; 43(4):103477. PubMed ID: 35537231
[TBL] [Abstract] [Full Text] [Related]
15. Significance of mid-radiotherapy 18F-fluorodeoxyglucose positron emission tomography/computed tomography in esophageal cancer.
Lee BM; Lee CG
Radiother Oncol; 2022 Jun; 171():114-120. PubMed ID: 35447284
[TBL] [Abstract] [Full Text] [Related]
16. maximum standardized uptake value change rate before and after neoadjuvant chemotherapy can predict early recurrence in patients with locally advanced esophageal cancer: a multi-institutional cohort study of 220 patients in Japan.
Murakami K; Yoshida N; Taniyama Y; Takahashi K; Toyozumi T; Uno T; Kamei T; Baba H; Matsubara H
Esophagus; 2022 Apr; 19(2):205-213. PubMed ID: 34993673
[TBL] [Abstract] [Full Text] [Related]
17.
Creff G; Jegoux F; Palard X; Depeursinge A; Abgral R; Marianowski R; Leclere JC; Eugene T; Malard O; Crevoisier R; Devillers A; Castelli J
J Nucl Med; 2022 Sep; 63(9):1378-1385. PubMed ID: 34887336
[TBL] [Abstract] [Full Text] [Related]
18. Improved prognostic stratification of patients with pN3b oral cavity cancer based on maximum standardized uptake value of metastatic nodes, lymph node ratio, and level of cervical nodal metastases.
Cheng NM; Kang CJ; Tsai CY; Lee LY; Lin CY; Hsueh C; Fan KH; Wang HM; Hsieh CH; Ng SH; Yeh CH; Lin CH; Tsao CK; Fang TJ; Huang SF; Lee LA; Fang KH; Wang YC; Lin WN; Hsin LJ; Yen TC; Liao CT
Oral Oncol; 2021 Dec; 123():105593. PubMed ID: 34768211
[TBL] [Abstract] [Full Text] [Related]
19. PET-Uptake Reduction into Lymph Nodes After Neoadjuvant Therapy is Highly Predictive of prognosis for Patients Who have Thoracic Esophageal Squamous Cell Carcinoma Treated with Chemoradiotherapy Plus Esophagectomy.
Nagaki Y; Motoyama S; Sato Y; Wakita A; Fujita H; Kemuriyama K; Sasaki Y; Imai K; Maeda E; Minamiya Y
Ann Surg Oncol; 2022 Feb; 29(2):1336-1346. PubMed ID: 34355333
[TBL] [Abstract] [Full Text] [Related]
20.
Lee S; Choi Y; Park G; Jo S; Lee SS; Park J; Shim HK
Technol Cancer Res Treat; 2021; 20():15330338211024655. PubMed ID: 34227434
[TBL] [Abstract] [Full Text] [Related]
[Next]
